Toxicology of Industrial Compounds

276 ENDOCRINE TOXICOLOGY OF THE THYROID
ATTERWILL, C.K., POOLE, A., JONES, R. and BROWN, R., 1989, Mechanistic
investigation of species-specific thyroid lesions induced by treatment with the
histamine H1 antagonist Temelastine (SK&F 93944) in rats, Food Chem.
Toxicol., 27, 681–90.
ATTERWILL, C.K., JONES, C. and BROWN, R., 1993, Thyroid Gland II—
Mechanisms of species-dependent thyroid toxicity, hyperplasia and neoplasia
induced by xenobiotics, in Atterwill, C.K. and Flack, J.D. (Eds) Endocrine
Toxicology, pp. 137–82, Cambridge: Cambridge University Press.
AYLWARD, S., WALKER, T. and ATTERWILL, C.K., 1994, Xenobiotic
modulation of thyroxine uptake and efflux by cultured rat hepatocytes in vitro
in relation to toxicological effects on the thyroid gland, Toxicol. in vitro (in
press).
BASTOMSKY, C.H., 1973, The biliary excretion of thyroxine and its glucuronic
acid conjugate in normal and Gunn rats, Endocrinology, 92, 35–40.
BASTOMSKY, C.H., 1974, Effects on a polychorinated biphenyl mixture
(Arochlor 1254) and DDT on the biliary thyroxine excretion in rats,
Endocrinology, 95, 1150–5.
BAYLISS, P.H. and TUNNBRIDGE, W.M.G., 1985, Endocrine disorders, in
Davies, D.M. (Ed.) Textbook of Adverse Drug Reactions, 3rd edn, pp. 335–51,
Oxford: Oxford Medical Publications.
BLONDEAU, J.P., 1986, Saturable binding of the thyroid hormone in isolated rat
hepatocytes, FEBS Lett., 204, 41–7.
BREWSTER, D.W., HOTZ, F., WARD, D.P., HEYDENS, W.E. and WILSON, A.
G.E., 1993, Evidence for a hormonally-mediated non-genotoxic mechanism of
action of alachlor-induced rat thyroid tumours, The Toxicologist, 13(1), 1440.
BUCKINGHAM, J. and GILLIES, J.G., 1991, Hypothalamus and pituitary gland
— xenobiotic-induced toxicity and models for its investigation, in Atterwill,
C.K. and Flack, J.M. (Eds), Endocrine Toxicology, pp. 83–115, Cambridge:
Cambridge University Press.
CAPEN, C.C. and MARTIN, S.L., 1989, The effects of xenobiotics on the structure
and function of the thyroid follicular and C-cells, Toxicolog. Pathol, 17(2),
266–92.
CAVALIERI, R.R. and PITT-RIVERS, R., 1981, The effects of drugs on the
distribu-tion and metabolism of thyroid hormones, Pharmacol. Rev., 33, 55–
80.
CHRISTENSON, W.R., BECKER, B.D., HONNG, H.D. and WAHLE, B.S., 1993,
Investigations into the mechanisms of decline in serum thyroxine following the
administration of a novel oxyacetamide, (FOE 5043), The Toxicologist, 13(1),
1438.
CI OMS, 1983, Safety requirements for the first use of new drugs and diagnostic
agents in man. A review of safety issues in early clinical trials of drugs.
Geneva: Council for International Organisations of Medical Sciences.
COLLETTA, G., CIRAFICI, A.M. and VECCHIO, G., 1986, Induction of the c-fos
oncogene by thyrotropic hormone in rat thyroid cells in culture, Science, 233,
458– 60.
COMER, C.P., CHENGELIS, C.P., LEVIN, S. and KOTSONIS, F.M., 1985,
Changes in thyroidal function and liver UDP-glucuronosyltransferase activity